Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 091616
Company: GLENMARK PHARMS LTD
Company: GLENMARK PHARMS LTD
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
LITHIUM CARBONATE | LITHIUM CARBONATE | 450MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
02/14/2011 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
10/13/2022 | SUPPL-12 | Labeling-Patient Package Insert, Labeling-Package Insert |
Label is not available on this site. |
||
02/05/2020 | SUPPL-9 | Labeling-Package Insert |
Label is not available on this site. |
||
12/20/2018 | SUPPL-8 | Labeling-Package Insert |
Label is not available on this site. |
||
12/07/2018 | SUPPL-7 | Labeling-Package Insert |
Label is not available on this site. |
LITHIUM CARBONATE
TABLET, EXTENDED RELEASE;ORAL; 450MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
LITHIUM CARBONATE | LITHIUM CARBONATE | 450MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 091616 | GLENMARK PHARMS LTD |
LITHIUM CARBONATE | LITHIUM CARBONATE | 450MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 076691 | HIKMA |
LITHIUM CARBONATE | LITHIUM CARBONATE | 450MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 202219 | MYLAN PHARMS INC |
LITHIUM CARBONATE | LITHIUM CARBONATE | 450MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | No | AB | 205663 | UNIQUE |